CS347191A3 - Angiotensin-ii-receptor blockers and their application - Google Patents

Angiotensin-ii-receptor blockers and their application

Info

Publication number
CS347191A3
CS347191A3 CS913471A CS347191A CS347191A3 CS 347191 A3 CS347191 A3 CS 347191A3 CS 913471 A CS913471 A CS 913471A CS 347191 A CS347191 A CS 347191A CS 347191 A3 CS347191 A3 CS 347191A3
Authority
CS
Czechoslovakia
Prior art keywords
angiotensin
receptor blockers
application
hyperplasia
pyrazole
Prior art date
Application number
CS913471A
Other languages
English (en)
Inventor
Holger Dr Heitsch
Rainer Dr Henning
Wolfgang Dr Linz
Bernward Prof Dr Scholkens
Hansjorg Dr Urbach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CS347191A3 publication Critical patent/CS347191A3/cs
Publication of CZ283236B6 publication Critical patent/CZ283236B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Recrystallisation Techniques (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CS913471A 1990-11-17 1991-11-15 Blokátory angiotensin-II-receptoru a jejich použití CZ283236B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036706A DE4036706A1 (de) 1990-11-17 1990-11-17 Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie

Publications (2)

Publication Number Publication Date
CS347191A3 true CS347191A3 (en) 1992-06-17
CZ283236B6 CZ283236B6 (cs) 1998-02-18

Family

ID=6418475

Country Status (20)

Country Link
US (1) US5236943A (cs)
EP (1) EP0492105B1 (cs)
JP (1) JP3370347B2 (cs)
KR (1) KR100221686B1 (cs)
CN (1) CN1049116C (cs)
AT (1) ATE108656T1 (cs)
AU (1) AU652590B2 (cs)
BR (1) BR9104918A (cs)
CA (1) CA2055637C (cs)
CZ (1) CZ283236B6 (cs)
DE (2) DE4036706A1 (cs)
DK (1) DK0492105T3 (cs)
ES (1) ES2060274T3 (cs)
HR (1) HRP940765B1 (cs)
HU (1) HU219404B (cs)
IE (1) IE66461B1 (cs)
MX (1) MX9102100A (cs)
NO (1) NO914482L (cs)
SK (1) SK280304B6 (cs)
ZA (1) ZA919056B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034114A (en) * 1990-12-14 2000-03-07 Smithkline Beecham Plc Medicament
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5266583A (en) * 1992-09-01 1993-11-30 Merck & Co., Inc. Angitotensin II antagonist
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist
RU2109736C1 (ru) * 1992-12-17 1998-04-27 Санкио Компани Лимитед Производные бифенила и способ их получения
US5908858A (en) 1996-04-05 1999-06-01 Sankyo Company, Limited 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
PT946507E (pt) * 1996-12-10 2004-02-27 Searle & Co Compostos de pirrolilo substituidos para o tratamento da inflamacao
AU6320998A (en) 1997-02-21 1998-09-09 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US6740649B2 (en) 2001-09-17 2004-05-25 Bristol-Myers Squibb Company Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)
ITTO20040264A1 (it) * 2004-04-28 2004-07-28 Rotta Res Lab Spa Nuovi derivati pirrolici ad attivita' angiotensina-ii antagonista
KR20090102883A (ko) * 2004-09-02 2009-09-30 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
JP4511550B2 (ja) * 2004-09-02 2010-07-28 テバ ファーマシューティカル インダストリーズ リミティド オルメサルタンメドキソミルの調製法
US20060258727A1 (en) * 2005-01-03 2006-11-16 Lilach Hedvati Olmesartan medoxomil with reduced levels of impurities
MX2010000465A (es) 2007-07-12 2010-08-30 Tragara Pharmaceuticals Inc Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores.
ES2572615T3 (es) 2008-08-15 2016-06-01 Nivalis Therapeutics, Inc. Nuevos inhibidores pirrólicos de S-nitrosoglutatión reductasa como agentes terapéuticos
US8470857B2 (en) * 2008-08-15 2013-06-25 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
DK2315590T3 (da) * 2008-08-15 2012-11-19 N30 Pharmaceuticals Inc Pyrrolinhibitorer af S-nitrosoglutathionreduktase
CN102816126A (zh) * 2011-06-07 2012-12-12 中国药科大学 具有心血管活性的胺磺酰芳基取代的三氮唑类衍生物、其制备方法及用途
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US488084A (en) * 1892-12-13 Blank-feeding device
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
JPS5671073A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd Imidazole derivative
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
DE4023215A1 (de) * 1990-07-21 1992-01-23 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
DE4036645A1 (de) * 1990-11-16 1992-05-21 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung

Also Published As

Publication number Publication date
HRP940765B1 (en) 2000-08-31
KR100221686B1 (ko) 1999-09-15
BR9104918A (pt) 1992-06-23
ES2060274T3 (es) 1994-11-16
EP0492105A2 (de) 1992-07-01
DE59102259D1 (de) 1994-08-25
AU8785891A (en) 1992-05-21
HU913581D0 (en) 1992-01-28
ZA919056B (en) 1992-07-29
IE66461B1 (en) 1995-12-27
JP3370347B2 (ja) 2003-01-27
CA2055637A1 (en) 1992-05-18
CA2055637C (en) 2003-11-11
NO914482D0 (no) 1991-11-15
NO914482L (no) 1992-05-18
EP0492105B1 (de) 1994-07-20
SK280304B6 (sk) 1999-11-08
MX9102100A (es) 1992-07-08
HRP940765A2 (en) 1997-08-31
IE913992A1 (en) 1992-05-20
HUT59599A (en) 1992-06-29
US5236943A (en) 1993-08-17
JPH04290823A (ja) 1992-10-15
DK0492105T3 (da) 1994-11-07
CN1062289A (zh) 1992-07-01
EP0492105A3 (en) 1992-07-29
HU219404B (hu) 2001-04-28
CN1049116C (zh) 2000-02-09
KR920009393A (ko) 1992-06-25
DE4036706A1 (de) 1992-05-21
ATE108656T1 (de) 1994-08-15
CZ283236B6 (cs) 1998-02-18
AU652590B2 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
CS347191A3 (en) Angiotensin-ii-receptor blockers and their application
MY104140A (en) Substituted pyrrole, pyrazole and triazole angiotensin ii antagonists
FI973255A7 (fi) Karbatsoliyhdisteiden käyttö verentungosta aiheuttavan sydämen toiminnanvajauksen hoidossa
DE69816109D1 (de) Substituierte imidazole zur behandlung von entzündlichen krankheiten
ZA925698B (en) Treatment of congestive heart failure.
HUT62575A (en) Process for producing substituted imidazole derivatives and pharmaceutical compositions comprising same
DE69322254D1 (de) Pyridyl-substituierte imidazole
ZA961927B (en) Method of treating cardiac inflammatory disease.
FI920442L (fi) Imidazol-, triatzol- och tetrazolderivat.
GR3018826T3 (en) Hydantoin derivative.
AU8844491A (en) Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
HU9300942D0 (en) Imidazole derivatives, medical preparatives containing them as well as method for producing them
DK600788D0 (da) Triazol- eller imidazolforbindelser, fremgangsmaade til fremstilling deraf og anvendelse af saadanne forbindelser som fungicider
IS3985A (is) Aðferð við framleiðslu á 1,2,3,9-tetrahýdró-9-metýl-3-[(2-metýl-1H-imídazól-1-ýl)metýl]-4H-karbasól-4-ón
EP0332306A3 (en) Preventing platelet loss using a thromboxane a2 receptor antagonist
FI973845A0 (fi) Imidatsoli-, triatsoli- ja tetratsolijohdannaisia
MY108525A (en) Substituted imidazoles.
AU644939C (en) Imidazole, triazole and tetrazole derivatives
IT1278360B1 (it) Protesi vascolare endoluminale, ad esempio per la correzione di aneurismi
AU5015496A (en) Agent for circulatory organs

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20111115